Appistry

About:

Appistry helps clinical labs, research institutions, and hospitals capitalize on genomics data.

Website: http://www.appistry.com

Twitter/X: appistry

Top Investors: St. Louis Arch Angels, Stuart Mill Venture Partners, eXome Capital

Description:

Appistry helps clinical labs, research institutions, and hospitals capitalize on genomics data so that they can practice genomically enhanced medicine. Their world-class bioinformatics tools, cloud services, and software streamline the analysis of next-generation sequencing (NGS) data and make genome-scale data actionable in guiding research projects and informing clinical decisions. The Appistry CloudDx products provide cloud-based systems that help clinical research programs conduct patient-centered translational research (CloudDx Translational) and hospitals implement genome-scale tests into routine patient care (CloudDx Clinical). Appistry also empowers researchers by providing world-class bioinformatics tools, cloud services, and software that streamline the analysis of NGS data and provide easy scale for moving research-developed pipelines into production.

Total Funding Amount:

$52.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)appistry.com

Founders:

Aaron Hinni, Bob Lozano, Guerry Semones, Michael Groner

Number of Employees:

11-50

Last Funding Date:

2015-02-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai